BACKGROUND AND AIMS: Chronic alcohol use is associated with lower gray matter volume, and we reported recently that alcohol use showed negative associations with widespread gray matter (GM) volume even among young adults. The current study aimed to test the strength of association between (1) alcohol use and GM volume; (2) alcohol use and white matter (WM) integrity; (3) cannabis use and GM volume; and (4) cannabis use and WM integrity among adults and adolescents. DESIGN AND SETTING: General linear models within large pooled cross-sectional samples of adolescents and adults who had participated in studies collecting substance use and neuroimaging data in the southwestern United States. PARTICIPANTS: The current analysis included adults aged 18-55 years (n = 853) and adolescents aged 14-18 years (n = 439) with a range of alcohol and cannabis use. MEASUREMENTS: The dependent variable was GM volume or WM integrity, with key predictors of alcohol use [Alcohol Use Disorders Identification Test (AUDIT) score] and cannabis use (past 30-day use). FINDINGS: Alcohol use showed large clusters of negative associations (ηp2 = 0.028-0.145, P < 0.001) with GM volume among adults and to a lesser extent (one cluster; ηp2 = 0.070, P < 0.05) among adolescents. Large clusters showed significant associations (ηp2 = 0.050-0.124, P < 0.001) of higher alcohol use with poorer WM integrity, whereas adolescents showed no significant associations between alcohol use and WM. No associations were observed between structural measures and past 30-day cannabis use in adults or adolescents. CONCLUSIONS: Alcohol use severity is associated with widespread lower gray matter volume and white matter integrity in adults, and with lower gray matter volume in adolescents.
BACKGROUND AND AIMS: Chronic alcohol use is associated with lower gray matter volume, and we reported recently that alcohol use showed negative associations with widespread gray matter (GM) volume even among young adults. The current study aimed to test the strength of association between (1) alcohol use and GM volume; (2) alcohol use and white matter (WM) integrity; (3) cannabis use and GM volume; and (4) cannabis use and WM integrity among adults and adolescents. DESIGN AND SETTING: General linear models within large pooled cross-sectional samples of adolescents and adults who had participated in studies collecting substance use and neuroimaging data in the southwestern United States. PARTICIPANTS: The current analysis included adults aged 18-55 years (n = 853) and adolescents aged 14-18 years (n = 439) with a range of alcohol and cannabis use. MEASUREMENTS: The dependent variable was GM volume or WM integrity, with key predictors of alcohol use [Alcohol Use Disorders Identification Test (AUDIT) score] and cannabis use (past 30-day use). FINDINGS:Alcohol use showed large clusters of negative associations (ηp2 = 0.028-0.145, P < 0.001) with GM volume among adults and to a lesser extent (one cluster; ηp2 = 0.070, P < 0.05) among adolescents. Large clusters showed significant associations (ηp2 = 0.050-0.124, P < 0.001) of higher alcohol use with poorer WM integrity, whereas adolescents showed no significant associations between alcohol use and WM. No associations were observed between structural measures and past 30-day cannabis use in adults or adolescents. CONCLUSIONS:Alcohol use severity is associated with widespread lower gray matter volume and white matter integrity in adults, and with lower gray matter volume in adolescents.
Authors: Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London Journal: Biol Psychiatry Date: 2004-01-01 Impact factor: 13.382
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Valentina Lorenzetti; Nadia Solowij; Sarah Whittle; Alex Fornito; Dan I Lubman; Christos Pantelis; Murat Yücel Journal: Br J Psychiatry Date: 2014-11-27 Impact factor: 9.319
Authors: Adolf Pfefferbaum; Torsten Rohlfing; Kilian M Pohl; Barton Lane; Weiwei Chu; Dongjin Kwon; B Nolan Nichols; Sandra A Brown; Susan F Tapert; Kevin Cummins; Wesley K Thompson; Ty Brumback; M J Meloy; Terry L Jernigan; Anders Dale; Ian M Colrain; Fiona C Baker; Devin Prouty; Michael D De Bellis; James T Voyvodic; Duncan B Clark; Beatriz Luna; Tammy Chung; Bonnie J Nagel; Edith V Sullivan Journal: Cereb Cortex Date: 2015-09-26 Impact factor: 5.357
Authors: Lindsay M Squeglia; Susan F Tapert; Edith V Sullivan; Joanna Jacobus; M J Meloy; Torsten Rohlfing; Adolf Pfefferbaum Journal: Am J Psychiatry Date: 2015-05-18 Impact factor: 18.112
Authors: Robert Whelan; Richard Watts; Catherine A Orr; Robert R Althoff; Eric Artiges; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Fabiana M Carvalho; Patricia J Conrod; Herta Flor; Mira Fauth-Bühler; Vincent Frouin; Juergen Gallinat; Gabriela Gan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Jean-Luc Martinot; Frauke Nees; Nick Ortiz; Marie-Laure Paillère-Martinot; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Hugh Garavan Journal: Nature Date: 2014-07-02 Impact factor: 49.962
Authors: Joanna Jacobus; Lindsay M Squeglia; Alejandro D Meruelo; Norma Castro; Ty Brumback; Jay N Giedd; Susan F Tapert Journal: Dev Cogn Neurosci Date: 2015-04-27 Impact factor: 6.464
Authors: J Cobb Scott; Adon F G Rosen; Tyler M Moore; David R Roalf; Theodore D Satterthwaite; Monica E Calkins; Kosha Ruparel; Raquel E Gur; Ruben C Gur Journal: Neuropsychopharmacology Date: 2019-02-19 Impact factor: 7.853
Authors: David A A Baranger; Catherine H Demers; Nourhan M Elsayed; Annchen R Knodt; Spenser R Radtke; Aline Desmarais; Lauren R Few; Arpana Agrawal; Andrew C Heath; Deanna M Barch; Lindsay M Squeglia; Douglas E Williamson; Ahmad R Hariri; Ryan Bogdan Journal: Biol Psychiatry Date: 2019-09-13 Impact factor: 13.382
Authors: Mina M Rizk; Harry Rubin-Falcone; Xuejing Lin; John G Keilp; Jeffrey M Miller; Matthew S Milak; M Elizabeth Sublette; Maria A Oquendo; R Todd Ogden; Nashaat A Abdelfadeel; Mohamed A Abdelhameed; J John Mann Journal: Psychiatry Res Neuroimaging Date: 2018-11-14 Impact factor: 2.376
Authors: Rachel E Thayer; Sophie L YorkWilliams; Kent E Hutchison; Angela D Bryan Journal: Psychiatry Res Neuroimaging Date: 2019-02-10 Impact factor: 2.376
Authors: J Cobb Scott; Samantha T Slomiak; Jason D Jones; Adon F G Rosen; Tyler M Moore; Ruben C Gur Journal: JAMA Psychiatry Date: 2018-06-01 Impact factor: 21.596
Authors: Jeremy Harper; Stephen M Malone; Sylia Wilson; Ruskin H Hunt; Kathleen M Thomas; William G Iacono Journal: Biol Psychiatry Date: 2021-01-20 Impact factor: 13.382
Authors: Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz Journal: Neuropsychopharmacology Date: 2021-03-03 Impact factor: 7.853